Low-dose clorthalidone offers clinicians a new option for initiating treatment that may mitigate well-known metabolic adverse effects.
Luke Halpern
Advertisement
Articles by Luke Halpern
The new policy is helping people who are taking insulin save money and helping others to afford it in the first place, says a study coauthor from the USC Sol Price School of Public Policy .
Advertisement
Latest Updated Articles
Insulin Prescription Fills Up Following Inflation Reduction Act Cap on Out-of-Pocket CostsPublished: July 31st 2023 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
2
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
3
Semaglutide CV Effects Appear Independent of Baseline Adiposity, Suggesting Disease-Modifying Potential
4
APOE ε4 and Inflammation Amplify Risk for Memory Decline in Women with Earlier Menopause
5
